[1] WHO, “Dengue vaccine: WHO position paper,” WHO, Geneva, 2016.
[2] D. Constenla and S. Clark, “Financing dengue vaccine introduction in the Americas: challenges and opportunities,” Expert Review of Vaccines, vol. 15, no. 4, pp. 547-559, 2016.
[3] D. Maharani and B. K. Dewi, “http://health.kompas.com/,” 15 June 2015. [Online]. Available: http://health.kompas.com/ read/2015/06/15/191031123/Kasus.DBD.Akibatkan.Kerugian.Ekonomi. [Accessed 30 November 2016].
[4] D. J. Gubler, E. E. Ooi, S. Vasudevan and J. Farrar, Dengue and Dengue Hemorrhagic Fever, 2nd ed., Croydon: CABI, 2014.
[5] WHO, Global Strategy for Dengue Prevention and Control, Geneva: WHO Press, 2012.
[6] D. Nathan, D. Dayal-Drager, D. Guzman and et al., Epidemiology, Burden of Disease and Transmission, Dengue, Guidelines for Diagnosis, Treatment, Prevention and Control, World Health Organization, 2009.
[7] V. Khode, G. Kabbin and K. Ruikar, “Association of ABO Rh Blood Group with Dengue Fever and Dengue Hemorrhagic Fever : A CaseControl Study,” Journal of Applied Hematology, vol. 4, no. 4, pp. 145-148, 2013.
[8] S. Thunguturthi, K. B. Reddy and B. R. Kiran, “Ratios of Age & Sex With Blood Group Prevalence’s in Dengue Fever,” Journal of Current Trends in Clinical Medicine & Laboratory Biochemistry, vol. 1, no. 2, pp. 24 - 27, 2013.
[9] F. A. Orsi, R. N. Angerami, B. M. Mazetto, S. K. Quaino, F. Santiago-Bassora, V. Castro, E. V. de Paula and J. M. Annichino-Bizzacchi, “Reduced Thrombin Formation and Excessive Fibrinolysis are Associated with Bleeding Complications in Patients with Dengue Fever: a case–control Study Comparing Dengue Fever Patients with and without Bleeding Manifestations,” BMC Infectious Diseases , vol. 13, no. 350, pp. 1 - 10, 2013.
[10] J. W. Young, R. V. Gibbons, A. L. Rothman, D. Tannitisupawong, A. Srikiatkhachorn, R. G. Jarman, A. Nisalak, S. Thammapalo and I.-K. Yoonb, “Dengue severity and blood group,” Dengue Bulletin, vol. 37, pp. 220 - 222, 2013.
[11] S. Kalayanarooj, R. Gibbons, D. Vaughn, S. Green, A. Nisalak, R. Jarman, M. Mammen and G. Perng, “Blood Group AB is Associated with Increased Risk for Severe Dengue Disease in Secondary Infections,” The Journal of Infectious Diseases, vol. 195, pp. 1014-1017, 2007.
[12] H. Nishiura, “Mathematical and Statistical Analyses of the Spread of Dengue,” Dengue Bulletin, vol. XXX, pp. 51-67, 2006.
[13] M. K. Mondal, M. Hanif and M. H. Al, “A Mathematical Analysis for Controlling the Spread of Nipah Virus Infection,” International Journal of Modelling and Simulation, 2017.
[14] A. Supriatna, “Human Population Rejection Behavior in Responding Wolbachia-infected Mosquito Release Program and Its Effect into Dengue Transmission: A Mathematical Modeling Approach,” Social Sciences and Interdisciplinary Behavior – Lumban Gaol et al. (Eds), pp. 335 - 342, 2016.
[15] Z. Hu, W. Ma and S. Ruan, “Analysis of SIR epidemic models with nonlinear incidence rate and treatment,” Mathematical Biosciences, vol. 238, pp. 12 - 20, 2012.
[16] A. Supriatna, “Estimating the Basic Reproduction Number of Dengue Transmission during 2002-2007 Outbreaks in Bandung, Indonesia,” Dengue Bulletin, vol. 33, pp. 21-22, 2009.
[17] P. Pongsumpun, “Age Structured Model for Symptomatic and Asymptomatic Infections of Dengue Disease,” International Journal of Modelling and Simulation, no. 2, pp. 199 - 205, 2009.
[18] G. Cruz-Pacheco, L. Esteva, J. A. Montaño-Hirose and C. Vargas, “Modelling the dynamics of West Nile Virus,” Bulletin of Mathematical Biology , vol. 67, p. 1157–1172, 2005.
[19] N. Samat and D. Percy , “Vector-borne Infectious Disease Mapping with Stochastic Difference Equations : an Analysis of Dengue Disease in Malaysia,” Journal of Applied Statistics, vol. 39, no. 9, pp. 2029-2046, 2012.
[20] P. Pongsumpun and I. Tang, “Transmission of Dengue Hemorrhagic Fever in an Age Structured Population,” Mathematical and Computer Modelling, vol. XXXVII, pp. 949-961, 2003.
[21] L. Esteva and C. Vargas, “Analysis of a Dengue Disease Transmission Model,” Mathematical Biosciences, vol. 150, pp. 131-151, 1998
[22] S. Ruan, W. Ma and Z. Hu, “Analysis of SIR Epidemic Models with Nonlinear Incidence Rate and Treatment,” Mathematical Biosciences, vol. 238, pp. 12-20, 2012.
[23] J. Kodaira and J. Souza Passos, “The Basic Reproduction Number in SIR Models : A Probabilistic Approach,” in Proceedings of the 9th Brazilian Conference on Dynamics Control and Their Applications, Brazil, 2010.
[24] R. M. May, Stability and Complexity in Model Ecosystems, Princeton: Princeton University Press, 2001.
[25] Z. Ma and J. Li, Dynamical Modeling and Analysis of Epidemics, World Scientific Publishing Co. Pte. Ltd, 2009.
[26] G. Bandung, “Technical Material Spatial Plan of Urban Bandung Area in the Year 2011-2031,” Bandung Government, Bandung, 2008.
[27] P. Pongsumpun, K. Patanarapelert, M. Sriprom, S. Varamit and I. Tang, “INFECTION RISK TO TRAVELERS GOING TO DENGUE FEVER ENDEMIC REGIONS,” SOUTHEAST ASIAN J TROP MED PUBLIC HEALTH, vol. 35, no. 1, pp. 155 - 159, 2004.
[28] D. Vaughn, S. Green, S. Kalayanarooj, B. Innis, S. Nimmannitya, S. Suntayakorn, A. Rothman, F. Ennis and A. Nisalak, “Dengue in the Early Febrile Phase: Viremia and Antibody Responses,” The Journal ofInfectious Diseases, pp. 322-330, 1997.
[29] F. Kristiani, N. A. Samat and S. b. Ab Ghani, “The SIR-SI model with age-structured human population for dengue disease mapping in Bandung, Indonesia,” Model Assisted Statistics and Applications, vol. 12, p. 151–161, 2017.